Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

285 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Hakala M, Järvinen P, Ahonen J, Forsberg S, Leirisalo-Repo M; FIN-RACo Trial Group. Puolakka K, et al. Among authors: hakala m. Arthritis Rheum. 2005 Jan;52(1):36-41. doi: 10.1002/art.20716. Arthritis Rheum. 2005. PMID: 15641055 Free article. Clinical Trial.
[Rheumatoid arthritis (updated Current Care guideline)].
Hakala M, Hannonen P, Helve T, Korpela M, Mattila K, Möttönen T, Varis T; Suomalaisen Lääkäriseuran Duodecimin ja Suomen Reumatologisen Yhdistyksen Asettama Työryhmä. Hakala M, et al. Duodecim. 2009;125(19):2131-2. Duodecim. 2009. PMID: 19938416 Finnish.
The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T; FIN-RACo Trial Group. Rantalaiho V, et al. Among authors: hakala m. Arthritis Rheum. 2009 May;60(5):1222-31. doi: 10.1002/art.24447. Arthritis Rheum. 2009. PMID: 19404945 Free article. Clinical Trial.
Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Leirisalo-Repo M. Puolakka K, et al. Among authors: hakala m. Arthritis Rheum. 2004 Jan;50(1):55-62. doi: 10.1002/art.11436. Arthritis Rheum. 2004. PMID: 14730599 Free article. Clinical Trial.
Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, Paimela L, Blåfield H, Puolakka K, Möttönen T; FIN-RACo Trial Group. Korpela M, et al. Among authors: hakala m. Arthritis Rheum. 2004 Jul;50(7):2072-81. doi: 10.1002/art.20351. Arthritis Rheum. 2004. PMID: 15248204 Free article. Clinical Trial.
The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy: a nationwide register-based study from 1995 through 2010.
Jämsen E, Virta LJ, Hakala M, Kauppi MJ, Malmivaara A, Lehto MU. Jämsen E, et al. Among authors: hakala m. Acta Orthop. 2013 Aug;84(4):331-7. doi: 10.3109/17453674.2013.810519. Epub 2013 Jun 25. Acta Orthop. 2013. PMID: 23992137 Free PMC article.
285 results